Skip to main content
OpenTrials

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

784 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Completed

An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.

NCT02246868

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Klinika Haematologii, Akademia Medyczna w Bialymstokiu, ul. Bialystok, Poland
  • Klinika Haematologii, Akademia Medyczna w Gdansku, u. Gdansk, Poland
  • Klinika Haematologii, Akademia Medyczna w Lodzi, ul. Lodz, Poland
  • Klinika Haematologii, Akademia Medyczna w Lublinie, ul. Lublin, Poland
View Trial Details
Completed

A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.

NCT02246881

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • Klinika Haematologii, Akademia Medyczna w Gdansku, ul. Debinki 7, 80-211 Gdansk, Poland
  • Klinika Haematologii, Akademia Medyczna w Lublinie, ul. Dr K Jaczewskiego 8, 20-090, Lublin, Poland
  • Klinika Haematologii, Akademia Medyczna w Lodzi, ul. Pabianicka 62, 93-513 Lodz, Poland
  • Haemophilia Centre, Addenbrooke's Hospital Hills Road, Cambridge, Cambridgeshire, United Kingdom
View Trial Details
Completed

An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.

NCT02250482

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Klinika Haematologii, Akademia Medyczna w Gdansku, ul. Debinki 7, 80-211 Gdansk, Poland
  • Klinika Haematologii, Akademia Medyczna w Lublinie, ul. Dr K Jaczewskiego 8, 20-090, Lublin, Poland
  • Klinika Haematologii, Akademia Medyczna w Poznaniu, ul. Szkolna 8/12, 61-833 Poznan, Poland
  • Haemophilia Centre, Addenbrooke's Hospital, Hills Road Cambridge, United Kingdom
View Trial Details
Completed

Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT01863758

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Medical University Vienna Vienna, Austria
  • University Multiprofile Hospital for Active Treatment Plovdiv, Bulgaria
  • Specialized Hospital for Active Treatment Sofia, Bulgaria
  • Multiprofile Hospital for Active Treatment Varna, Bulgaria
View all 20 locations
View Trial Details
Completed

A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A

NCT02920398

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Torrance, California, United States
  • Novo Nordisk Investigational Site Iowa City, Iowa, United States
  • Novo Nordisk Investigational Site Baltimore, Maryland, United States
  • Novo Nordisk Investigational Site Dayton, Ohio, United States
View all 14 locations
View Trial Details

Related conditions